IFB Adipositas
Sara Vieira-Silva
MetaCardis is a major EU-funded research project investigating the role of gut microbes in cardiometabolic diseases (CMDs) . The main investigatory approach is metagenomics and the use of clinical and experimental studies.
The goal of MetaCardis is to investigate the impact of qualitative and quantitative changes in gut microbiota on the pathogenesis of cardiometabolic diseases and their associated co-morbidities. This will be achieved through a combination of clinical and experimental studies that will be carried out at a range of organisations located across Europe. A major objective will be to translate clinical and fundamental discoveries into new diagnostics and preventive approaches. More specifically, we want to use di
Various centres of excellence now exist in Europe that focus on translational medicine and personalised patient care. This is seen as a major development in terms of addressing clinical needs in cardiometabolic and nutrition-related diseases. Specifically national efforts in Germany, Denmark and France are focussing on innovation in care, translational research and also training of a critical mass of clinicians and researchers in cardiometabolic diseases. While these efforts are delivering very noticeable d
IFB Adipositas
Sara Vieira-Silva